mRNA-2416
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mRNA-2416, covering 2024-07-31 to 2024-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies [Phase 1, Phase 2]